Dr. Palapattu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 E Medical Center Dr
Ann Arbor, MI 48109Phone+1 734-936-4000
Summary
- Ganesh Palapattu, MD, is a urologist based in Ann Arbor, MI, specializing in urologic oncology. He completed his residency in urology at UCLA and graduated from Baylor College of Medicine in 1997. Currently, he serves as Department Chair and a Professor at the University of Michigan Medical Center. Dr. Palapattu's areas of expertise include prostate cancer, minimally invasive surgery, and kidney cancer. He has contributed multiple publications to leading journals and participated in clinical trials, such as S0931. His accolades include being named a Regional Top Doctor and being a Fellow of the American College of Surgeons.
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Urology, 1997 - 2003
- Baylor College of MedicineClass of 1997
Certifications & Licensure
- CA State Medical License 1999 - Present
- TX State Medical License 2009 - 2026
- MI State Medical License 2012 - 2025
- NY State Medical License 2005 - 2010
- MD State Medical License 2003 - 2005
- American Board of Urology Urology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow (FACS) American College of Surgeons
Clinical Trials
- S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery Start of enrollment: 2011 Apr 01
Publications & Presentations
PubMed
- What's in a Name? Why Words Matter in Advanced Prostate Cancer.William K Oh, Neeraj Agarwal, Alan Bryce, Pedro Barata, Courtney Bugler
European Urology. 2025-02-01 - Differences in mutations across tumour sizes in clear-cell renal cell carcinoma.Steven M Monda, Benjamin W Carney, Allison M May, Shuchi Gulati, Simpa S Salami
BJU International. 2025-02-01 - Clinical Validation of MyProstateScore 2.0 Testing Using First-Catch, Non-DRE Urine.Jeffrey J Tosoian, Yuping Zhang, Jacob I Meyers, Spencer Heaton, Javed Siddiqui
The Journal of Urology. 2025-01-21
Journal Articles
- Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic ImplicationsPetros Grivas, Phillip Palmbos, Ganesh Palapattu, Jeffrey S Montgomery, Alon Z Weizer, European Urology
- Detailed Pathologic Analysis on the Co-Occurrence of Non-Seminomatous Germ Cell Tumor Subtypes in Matched Orchiectomy and Retroperitoneal Lymph Node DissectionsDavid Smith, Ganesh S Palapattu, Aaron Udager, Scott A Tomlins, Alon Z Weizer, Rohit Mehra, Angela Wu, Madelyn Lew, Jeffrey S Montgomery, Samuel D Kaffenberger, Khaled..., Medical Oncology
Press Mentions
- Urine-Based Test Detects Aggressive Prostate CancerJanuary 28th, 2025
- $30M Gift to Establish the Ronald Weiser Center for Prostate Cancer at Michigan MedicineDecember 15th, 2021
- SynDevRx Assembles Prostate Cancer Medical Advisory Board to Oversee Drug Candidate That Targets Link Between Obesity and Prostate CancerJanuary 25th, 2021
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: